Form 4 · Filed Jun 1, 2026, 09:01 PM UTC
PCSA/Processa Pharmaceuticals, Inc.
Young David — Pres. Research & Development
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
1 row| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 29, 2026 | P | buy | 1,786 | $3 | $4,590 | 17,131 |
Source: SEC EDGAR raw filing ↗ · Accession 0000897069-26-001295